Indian pharma major Bharat Biotech has claimed to have invented the candidate vaccine for COVID-19, named Covaxin, which has been approved for trial on humans by Indian Council of Medical Research (ICMR).
"The research will decide if contributors acquiring the opportunity vaccine acquire antibodies that lead to virus resistance for COVID-19", a release from the Lynn Wellness Science Institute of Colorado Springs study. Emory, which conducted Phase 1 trials for this vaccine candidate, will also participate in the upcoming Phase 3 trials. Bhushan added that one has been developed by the Bharat Biotech International Limited in collaboration with ICMR and another one by Zydus Cadila Healthcare Ltd.
"Establishing a unified clinical trial network is a key element of President Trump's Operation Warp Speed, which aims to deliver substantial quantities of a safe, effective vaccine by January 2021", said HHS Secretary Alex Azar.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies meant to protect people from COVID-19.
Several countries are pushing to have vaccines ready as soon as possible, including the United States and the United Kingdom, both of which have vaccines in advanced levels of testing.
Ryder Cup postponed to 2021 due to COVID-19 pandemic
They need to hear them for themselves - that is what makes the Ryder Cup such an attractive proposition for them. Although the tour has no stake in the Ryder Cup , its players are participants.
GSK, the world's largest vaccine maker, on Tuesday announced the latest partnership for its vaccine booster technology to develop and test a potential COVID-19 shot with Canadian biopharmaceutical firm Medicago.
The PLA has its own approval process for "military specifically-needed drugs", the report said, and approved the military use of the candidate developed by its research unit and CanSino last month.
It has since shifted its focus overseas, but only a handful of countries have shown willingness to collaborate - UAE, Canada, Brazil, Indonesia and Mexico. If individuals become infected with COVID-19, the study said staff will work with them to make sure they receive the proper care.
China introduced a law a year ago to regulate the vaccine industry, with heavier penalties for selling and making fake or low-quality vaccines than other drug products. "But it is satisfying for us that there are two indigenous companies working on vaccines in India", he said.